oxybutynin chloride

Product NDC
70518-2710
11-digit product format
705182710
Labeler code
70518
Product ID
70518-2710_d6e6445d-be8f-6894-e053-2995a90a8314
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
oxybutynin chloride
Dosage form
TABLET, EXTENDED RELEASE
Route
ORAL
Labeler
REMEDYREPACK INC.
Application
ANDA207138
Marketing category
ANDA
Marketing start
2020-04-24
Marketing end
0000-00-00
Substance
OXYBUTYNIN CHLORIDE
Active strength
15 mg/1
Pharmacologic classes
Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]
NDC exclude flag
No
Listing certified through
2023-12-31
Current FDA listing
Historical FDA.report record

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
70518-2710-02022-01-31C16284748780-1d6a99b39-b0f5-a426-e053-dadaa90af4c22fe3b3cf-c215-41a8-9967-5919686fba3e
70518-2710-02022-01-28C16284748780-1d6a99b39-b0f5-a426-e053-dadaa90af4c22fe3b3cf-c215-41a8-9967-5919686fba3e

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionMarketing startMarketing endSampleExclude flagStatus
70518-2710-07051827100090 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (70518-2710-0) 2020-04-240000-00-00NoNoCurrent